The Role of JMY in p53 Regulation

被引:18
作者
Adighibe, Omanma [1 ]
Pezzella, Francesco [1 ]
机构
[1] Univ Oxford, John Radcliffe Hosp, Radcliffe Dept Med, Nuffield Div Clin Lab Sci, Oxford OX3 DU, England
关键词
p53; JMY; regulation; apoptosis; motility; ACTIN NUCLEATION FACTOR; DNA-DAMAGE; TRANSCRIPTION COFACTOR; CELL-ADHESION; HUMAN CANCER; MOTILITY; POLYMERIZATION; ACETYLATION; ACTIVATION; SUPPRESSOR;
D O I
10.3390/cancers10060173
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Following the event of DNA damage, the level of tumour suppressor protein p53 increases inducing either cell cycle arrest or apoptosis. Junctional Mediating and Regulating Y protein (JMY) is a transcription co-factor involved in p53 regulation. In event of DNA damage, JMY levels also upregulate in the nucleus where JMY forms a co-activator complex with p300/CREB-binding protein (p300/CBP), Apoptosis-stimulating protein of p53 (ASPP) and Stress responsive activator of p53 (Strap). This co-activator complex then binds to and increases the ability of p53 to induce transcription of proteins triggering apoptosis but not cell cycle arrest. This then suggests that the increase of JMY levels due to DNA damage putatively "directs" p53 activity toward triggering apoptosis. JMY expression is also linked to increased cell motility as it: (1) downregulates the expression of adhesion molecules of the Cadherin family and (2) induces actin nucleation, making cells less adhesive and more mobile, favouring metastasis. All these characteristics taken together imply that JMY possesses both tumour suppressive and tumour metastasis promoting capabilities.
引用
收藏
页数:10
相关论文
共 37 条
[1]   JMY protein, a regulator of P53 and cytoplasmic actin filaments, is expressed in normal and neoplastic tissues [J].
Adighibe, Omanma ;
Turley, Helen ;
Leek, Russell ;
Harris, Adrian ;
Coutts, Amanda S. ;
La Thangue, Nick ;
Gatter, Kevin ;
Pezzella, Francesco .
VIRCHOWS ARCHIV, 2014, 465 (06) :715-722
[2]   Out of the jaws of death: PRMT5 steers p53 [J].
Berger, Shelley L. .
NATURE CELL BIOLOGY, 2008, 10 (12) :1389-1390
[3]   Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression [J].
Bossi, G ;
Lapi, E ;
Strano, S ;
Rinaldo, C ;
Blandino, G ;
Sacchi, A .
ONCOGENE, 2006, 25 (02) :304-309
[4]   Restoration of wild-type p53 function in human cancer: Relevance for tumor therapy [J].
Bossi, Gianluca ;
Sacchi, Ada .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2007, 29 (03) :272-284
[5]   A nucleator arms race: cellular control of actin assembly [J].
Campellone, Kenneth G. ;
Welch, Matthew D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2010, 11 (04) :237-251
[6]   DNA Damage Signals through Differentially Modified E2F1 Molecules To Induce Apoptosis [J].
Carnevale, Jasmyne ;
Palander, Oliva ;
Seifried, Laurie A. ;
Dick, Frederick A. .
MOLECULAR AND CELLULAR BIOLOGY, 2012, 32 (05) :900-912
[7]   Arginine methylation controls growth regulation by E2F-1 [J].
Cho, Er-Chieh ;
Zheng, Shunsheng ;
Munro, Shonagh ;
Liu, Geng ;
Carr, Simon M. ;
Moehlenbrink, Jutta ;
Lu, Yi-Chien ;
Stimson, Lindsay ;
Khan, Omar ;
Konietzny, Rebecca ;
McGouran, Joanna ;
Coutts, Amanda S. ;
Kessler, Benedikt ;
Kerr, David J. ;
La Thangue, Nicholas B. .
EMBO JOURNAL, 2012, 31 (07) :1785-1797
[8]   Hypoxia-driven cell motility reflects the interplay between JMY and HIF-1α [J].
Coutts, A. S. ;
Pires, I. M. ;
Weston, L. ;
Buffa, F. M. ;
Milani, M. ;
Li, J-L ;
Harris, A. L. ;
Hammond, E. M. ;
La Thangue, N. B. .
ONCOGENE, 2011, 30 (48) :4835-4842
[9]   Mdm2 widens its repertoire [J].
Coutts, Amanda S. ;
La Thangue, Nicholas B. .
CELL CYCLE, 2007, 6 (07) :827-829
[10]   Mdm2 targets the p53 transcription cofactor JMY for degradation [J].
Coutts, Amanda S. ;
Boulahbel, Houda ;
Graham, Anne ;
La Thangue, Nicholas B. .
EMBO REPORTS, 2007, 8 (01) :84-90